NCT07077811View on ClinicalTrials.gov

The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.

NAEnrolling by invitationINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2028

Conditions
Cardiovascular DiseasesHeart FailureAtrial Fibrillation (AF)HFpEF - Heart Failure With Preserved Ejection Fraction
Interventions
PROCEDURE

pulsed field ablation

Medtronic Pulse Select pulsed field ablation

DRUG

antiarrhythmic drug

treated with class I or class III antiarrhythmic drugs

Trial Locations (1)

226001

Affiliated hospital of Nantong University, Nantong

All Listed Sponsors
lead

Affiliated Hospital of Nantong University

OTHER